|
⚲
|
| Keyboard |
| Mack Anthony P
✚
|
|
|---|---|
| CIK # | 0001818483 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001818483] | |
| 4 | [0001818483] | |
| SC 13G | [0001818483] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Mack Anthony P | Virpax Pharmaceuticals Inc | [2022-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Virpax Pharmaceuticals Inc | |
| Mack Anthony P |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2023-01-25 | Grant | 125,000 | $0.00 | |
|
Virpax Pharmaceuticals Inc VRPX
Common Stock, $0.00001 par value
|
2022-05-18 | Buy | 75,750 | $1.34 | 101,505 |
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2022-01-31 | Grant | 150,000 | $0.00 | |
|
Virpax Pharmaceuticals Inc VRPX
Common Stock, $0.00001 par value
|
2021-11-18 | Buy | 25,125 | $3.99 | 100,249 |
|
Virpax Pharmaceuticals Inc VRPX
Stock Option (right to buy) · derivative
|
2021-04-07 | Grant | 50,000 | $0.00 |